BioSpace News Archive

SCYNEXIS, Inc. (NASDAQ : SCYX) today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-10. The effective time of the reverse stock split will be 12:01 a.m. ET on July 17, 2020. SCYNEXIS common stock will begin trading on a split-adjusted basis commencing upon market open on July 17, 202

Stand Up To Cancer today announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities.

Ambra Health, makers of the leading cloud-based, medical image management suite and Invenio Imaging, a leader in rapid intraoperative tissue imaging with Stimulated Raman Histology (SRH), today announced a partnership that integrates Ambra’s image management technology with Invenio’s NIO Laser Imaging System.

CDC reports UV-C Light Germicidal Irradiation (UVGI) as one of “most promising methods” for Coronavirus decontamination of facemasks. 1 RxAir400 employs powerful UVGI proven to inactivate >99.9% of viruses and pathogens Reduces virus exposure risk in schools, restaurants, retail and office facilities

R.R. Donnelley & Sons Company (RRD) (NYSE: RRD), a leading global provider of marketing and business communications, today introduced a holistic supply chain solution for the production, kitting, and fulfillment of point-of-care and at-home diagnostic test kits.

Perspectum, a leading medical imaging company, has begun work on expanding its offering by including cardiac and lung imaging in many new research projects, specifically in Coronavirus multiorgan imaging studies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200716005147/en/ Recently launched COVERSCAN and Modify are two such s

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2020 financial results will be released after market close on Thursday, August 6, 2020. Starting at 4:30 p.m. ET, Coherus’ management team will host a conference call to discuss financial results and provide a general business update. After releasing second quarter financial results, the Company will post them on the Coherus website at https:

The International Association for the Study of Pain has revised the definition of pain for the first time since 1979, the result of a years-long process that the association hopes will lead to new ways of assessing pain.

Company taking further steps to help ensure health and safety of customers and team members, supporting latest recommendations from CDC

Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19.